The most powerful MRI in the world studies the effects of COVID and myalgic encephalomyelitis / brain fatigue.

Published Date: 15 Mar 2023

For the first time in the world, researchers at Griffith University have used ultra-high magnetic field (7 Tesla) MRI to examine how COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS ) affect the same brain.

Read Full News

Latest News

TBI History Tied to False-Negative Alzheimer’s Blood Test

FDA-approved p-tau217/amyloid-beta-42 testing missed more amyloid PET-positive cases among older adults with prior TBI, a cross-sectional cohort study shows.

p-Tau217 May Predict Cognitive Decline Years Before Symptoms

Higher plasma p-tau217 levels identified cognitively sound older adults at greater risk for future cognitive impairment up to a decade before symptom onset.

ENTF Stim Boosts Freedom From Disability Post-Stroke

Electromagnetic stimulation combined with physical and occupational therapy is linked to a higher rate of freedom from disability post-stroke than sham, a study shows.

Rituximab Noninferior to Ocrelizumab in Relapsing MS

Rituximab is noninferior to ocrelizumab in suppressing disease activity in newly diagnosed multiple sclerosis, with a similar incidence of adverse events, a new trial shows.

FDA Neurology Roundup: June 2026

A monthly snapshot of FDA activity involving therapies for the prevention and treatment of neurologic diseases.

AI Uncovers ‘Invisible’ Cortical Lesions in MS MRI Scans

AI-enhanced analysis of conventional MRI scans reveals thousands of hidden cortical lesions in multiple sclerosis, potentially opening a new window into disease progression.

Todays Updates

Virtual Help Doubles Cancer Patients’ Smoking Quit Rate

Programs offering telehealth counseling and nicotine replacement products should be part of routine oncology care, researchers say.

MRD Tied to PFS in Lymphoma Patients on Epcoritamab

Researchers evaluate minimal residual disease status in 128 adults with relapsed or refractory follicular lymphoma treated with epcoritamab.

Germline Profiling May Improve Risk Stratification in t-MNs

A new study explores whether germline profiling could refine the subclassification and prognosis of therapy-related myeloid neoplasms beyond treatment history alone.

Todays Updates

Virtual Help Doubles Cancer Patients’ Smoking Quit Rate

Programs offering telehealth counseling and nicotine replacement products should be part of routine oncology care, researchers say.

MRD Tied to PFS in Lymphoma Patients on Epcoritamab

Researchers evaluate minimal residual disease status in 128 adults with relapsed or refractory follicular lymphoma treated with epcoritamab.

Germline Profiling May Improve Risk Stratification in t-MNs

A new study explores whether germline profiling could refine the subclassification and prognosis of therapy-related myeloid neoplasms beyond treatment history alone.

Latest News

FDA-approved p-tau217/amyloid-beta-42 testing missed more amyloid PET-positive cases among older adults with prior TBI, a cross-sectional cohort study shows.

Higher plasma p-tau217 levels identified cognitively sound older adults at greater risk for future cognitive impairment up to a decade before symptom onset.

Electromagnetic stimulation combined with physical and occupational therapy is linked to a higher rate of freedom from disability post-stroke than sham, a study shows.

Rituximab is noninferior to ocrelizumab in suppressing disease activity in newly diagnosed multiple sclerosis, with a similar incidence of adverse events, a new trial shows.

A monthly snapshot of FDA activity involving therapies for the prevention and treatment of neurologic diseases.

AI-enhanced analysis of conventional MRI scans reveals thousands of hidden cortical lesions in multiple sclerosis, potentially opening a new window into disease progression.

News All Time

RFK Jr. Seeks to Peek at Americans' Medical Records for Clues on Autism and Vaccines

Some public health leaders have raised doubts that giving access would be legal or even useful

MAHA's Autism Treatments: Camel's Milk, Stem Cell Injections, and Spelling Therapy

Experts say some of the methods may be fraudulent

Primitive Reflexes May Predict Dementia

Two or more frontal release signs in cognitively normal people tied to higher risk of dementia

Brain Institute Halts Research; Parkinson's Deaths Fall; Meet the 'Dementia Rebels'

News and commentary from the world of neurology and neuroscience

Alzheimer's May Be Worse for People Taking Popular Supplement

Glucosamine tied to faster progression in people with established neurodegeneration

Genetic Risk of Autism, ADHD Decreased as Diagnoses Increased

Study offers "new perspective for ongoing debates" about increasing diagnoses, researchers say

Report: Law Firms Cheated in Filing Claims With NFL's Concussion Settlement Fund

The fund was meant to last for 65 years

Ebola's Brain Effects Persist More Than 7 Years After Infection

Many survivors still had neurologic symptoms, most notably memory loss

Alzheimer's and Psilocybin; Migraine and Driving; What New MS Criteria Reveal

News and commentary from the world of neurology and neuroscience

Hospital's Brain Tumor Cluster; Princess's Lung Transplant; Plastic Surgery Deaths

Health news and commentary gathered by MedPage Today staff

Brain Disorders and TBI May Fuel Each Other

Two-way relationships with traumatic brain injury emerge in a large study of veterans

FDA Reverses Course on Neuro Drugs; Omega-3s and Dementia; Brain Death Test Lawsuit

News and commentary from the world of neurology and neuroscience

ALS Testing Expected to Drive Sharp Rise in Clinic Visits

Genetic screening in the wake of new therapies will identify more at-risk relatives

First State Bans Paraquat, a Weed Killer Linked to Parkinson's Disease

The herbicide is used widely in the U.S. but banned in China and Europe

Study Suggests No Link Between Prenatal Tylenol and Risks for Autism, ADHD

Research shows the power of negative control analyses

NFL Star Diagnosed With ALS at 39; 'No Surprises' Windfall; Arizona Plague Scare

Health news and commentary gathered by MedPage Today staff

Recommended News For You

Telemedicine services linked to reducing excess mortality

The need for more Latinx participants in Alzheimer's trials is urgent.

ctDNA Predicts Relapse in Locally Advanced Cervical Cancer

Olaparib-Abiraterone in mCRPCs Selected by Biomarkers Outperforms Each Agent by Itself.

Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven

Review looks at potential treatment targets in the tumor microenvironment.

A retrospective study examined the role of CA 19-9 and CEA in duodenal adenocarcinoma prognosis.

Recommended Articles For You

Integrative Clinical Genomics of Metastatic Cancer: Decoding Tumor Evolution for Precision Oncology 

Understanding Mesenteric Masses: Symptoms, Diagnosis, and Treatment Options 

Emerging Models in Oncology for Specialists 

Advancing Cancer Trials: Integrating Master Protocols and Immunotherapy Guidelines 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Pain’s Toll: Frailty Risk for Childhood Cancer Survivors

2.

Biomarker Flags 10-Fold Recurrence Risk in Testicular Cancer

3.

Chemo causes lasting physical decline in breast cancer survivors

4.

Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy

5.

FDA Approves Novel Targeted Therapy for Rare Blood Cancer

1.

Integrated Trends in Hematology for Modern Medicine

2.

The Benefits and Risks of Transurethral Resection of Bladder Tumor 

3.

Uncovering the Causes of Thrombocytosis: A Journey to Improved Health

4.

Liquid Biopsy: A Game-Changer in T-Cell Lymphoma Detection and Management

5.

MMA Embolization in Chronic Subdural Hematoma: Evidence, Outcomes, and Gaps

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients

2.

First Line Combination Therapy- The Overall Survival Data in NSCLC Patients

3.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV

4.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion

5.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot